Peter Maag - 07 Jul 2025 Form 4 Insider Report for CareDx, Inc. (CDNA)

Reporting relationship: Director
Issuer ticker: CDNA
Reported as of: 07 Jul 2025
Net transaction value: -$185,831
SEC form: 4
Accepted by SEC: 10 Jul 2025, 16:04:04 UTC
Prior SEC filing: 20 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Peter Maag

Key filing fact

Peter Maag filed Form 4 for CareDx, Inc. (CDNA) on 10 Jul 2025.

Key facts

This page summarizes Peter Maag's Form 4 filing for CareDx, Inc. (CDNA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Jul 2025, 16:04.

Change

Previous filing in this sequence was filed on 20 Jun 2025.
Current net transaction value: -$185,831.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001613855 Primary reporting owner

Maag Peter

Relationship: Director
Address: C/O CAREDX, INC., 8000 MARINA BOULVARD, BRISBANE
Signature: /s/ Peter Maag
Signature date: 10 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDNA transaction

Common Stock

Sale

Transaction value: $185,831
Shares: -10,000
Change %: -3.1%
Price: $18.58
Shares after: 308,846
Date: 07 Jul 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 21, 2024.

Footnote F2

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.40 to $18.86 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.